A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #395

[Effect of age, different light conditions, melatonin, and epitalon on lysosomal proteinase activity in the liver and kidneys of rats].

Rendakov NL, Tiutiunnik NN, Vinogradova IA Advances in gerontology = Uspekhi gerontologii. 2006.
PubMed: 17152724
Weak / noneAnimal (in vivo)Mentions: Epitalon

Editor's note

A rodent biochemistry study of how aging, lighting, melatonin, and epithalon affect lysosomal protease (cathepsin B and D) activity in liver and kidney. The authors report that aging and disrupted light/dark cycles lowered cathepsin activity, and that melatonin and epithalon further reduced cathepsin D in liver under standard lighting, with cathepsin B declining across conditions; they interpret this as an inhibitory effect on protein turnover and general metabolism. This is a narrow enzymatic readout with no functional or clinical endpoint, no effect sizes in the abstract, and epithalon's contribution entangled with melatonin and lighting. It belongs to the single-lineage pineal-peptide literature. Whether reduced protein-degradation enzyme activity is beneficial is not established here. These are preclinical findings; human data are needed before clinical conclusions can be drawn.

Plain-language abstract

Researchers studied enzymes called cathepsins (types B and D), which help break down proteins inside cell compartments called lysosomes, in the liver and kidneys of rats. They looked at how these enzymes changed with age, under different lighting conditions, and with the hormone melatonin or the peptide epithalon. Aging lowered cathepsin activity in the liver, and unusual lighting — constant light or constant darkness — brought on this decline earlier. Giving melatonin or epithalon lowered cathepsin D activity in the liver, but only under the normal alternating light/dark cycle, while cathepsin B activity dropped under all lighting conditions. The authors suggest these pineal factors slow protein breakdown and general metabolism. The abstract gives no numerical results, and it is not established whether lower activity of these enzymes is helpful or harmful. No human data or side effects are reported. This is early animal research.